This national provider of pharmacy services to long-term care facilities paid $2.75 million to resolve allegations that its dispensing practices allowed opioids and other controlled substances to be dispensed without a prescription. Our relator, a former pharmacist at AlixaRx, alleged that the company was submitting false claims for invalid prescriptions after abusing the “emergency prescription” provisions of the Controlled Substances Act.